ATL, while I love what you're saying about the potential of DCVax-L here, I suspect that we all know it will be cheaper in many countries, and probably more expensive here in the US, though the new administration may lessen what's paid here to support new drug development.
I believe that if anecdotal evidence exists of benefit in pancreatic cancer, for instance, Drs. won't wait for approval. In the beginning only the wealthiest may get it, but as evidence grows, it won't be denied to those who can benefit, and insurance will pay.
My point is, it won't take all that long before DCVax-L is being used on many solid cancers, and of course the revenue figures will go through the roof.
I believe the big question will be, what do surgical oncologists do with the tumors they remove once more information is out about making the vaccine. I believe that they'll cryogenically preserve the tumor in the hope that later a vaccine can be made from it. NWBO will in no way be paid until a decision is made to make the vaccine, but that may come faster than people think.
I don't wish it on anyone, but if someone you knew was having a cancer surgically removed, wouldn't you suggest cryogenic preservation. I would.
Gary
Bullish
Market Data 
Markets 
AI
